中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23
作者:  He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie;  She, Yun-Lang;  Wang, Ting-Ting;  Yang, Yang;  Sun, Xi-Wen;  Belluomini, Lorenzo;  Watanabe, Satoshi;  Dong, Di;  Tian, Jie;  Xie, Dong
Adobe PDF(3742Kb)  |  收藏  |  浏览/下载：361/44  |  提交时间：2022/06/10
Tumor biomarkers  immunotherapy  lung neoplasms  programmed cell death 1 receptor (PD-1 receptor)  biostatistics  
Patient-Level Prediction of Multi-Classification Task at Prostate MRI Based on End-to-End Framework Learning From Diagnostic Logic of Radiologists 期刊论文
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2021, 卷号: 68, 期号: 12, 页码: 3690-3700
作者:  Shao, Lizhi;  Liu, Zhenyu;  Yan, Ye;  Liu, Jiangang;  Ye, Xiongjun;  Xia, Haizhui;  Zhu, Xuehua;  Zhang, Yuting;  Zhang, Zhiying;  Chen, Huiying;  He, Wei;  Liu, Cheng;  Lu, Min;  Huang, Yi;  Sun, Kai;  Zhou, Xuezhi;  Yang, Guanyu;  Lu, Jian;  Tian, Jie
收藏  |  浏览/下载：323/0  |  提交时间：2021/12/28
Magnetic resonance imaging  Principal component analysis  Pathology  Lesions  Optimization  Task analysis  Predictive models  Gleason score  prostate cancer  patient-level prediction  joint optimization  MRI  reinforcement learning  
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images 期刊论文
Theranostics, 2020, 卷号: 0, 期号: 0, 页码: 0
作者:  Tian, Panwen;  He, Bingxi;  Dong, Di;  Mu, Wei;  Liu, Kunqin;  Liu, Li;  Zeng, Hao;  Liu, Yujie;  Jiang, Lili;  Zhou, Ping;  Huang, Zhipei;  Li, Weimin;  Tian, Jie
浏览  |  Adobe PDF(1539Kb)  |  收藏  |  浏览/下载：312/123  |  提交时间：2020/10/25
PD-L1 expression  deep learning  computed tomography  immunotherapy  non-small cell lung cancer.